Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts

By Takashi Nakamura, Yuuki Imai, Takahiro Matsumoto, Shingo Sato, Kazusane Takeuchi, K. Igarashi, Y. Harada, Y. Azuma, A. Krust, Yoko Yamamoto and 9 more. 2007

1,011 citations recorded by the source corpus.

Subfields: Genetics, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/ed55d686f6ffc6ce14c3aab58bf5684ab8a6a376

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Xu Feng
2. J. McDonald

In Oncology

1. Xu Feng
2. J. McDonald

Citations in the corpus

• Estrogen and the Skeleton (2012, neutral): “These findings contrast with the clear phenotype noted earlier in mice with osteoclastspecific deletion of ERα (28, 29).”
• Disorders of bone remodeling. (2011, background): “Second, estrogen directly targets mature osteoclasts to promote apoptosis of osteoclasts via the action of the Fas/Fas ligand system (75, 76).”
• Endocrine regulation of male fertility by the skeleton. (2011, neutral): “To date, the study of the interplay between gonads and bone has focused on the mechanism whereby sex steroid hormones affect bone mass accrual (Manolagas et al., 2002; Nakamura et al., 2007).”